New strategies for characterising and monitoring protein-surface interactions: application to a biosensor for diabetic’s blood glucose regime effectiveness. This project aims to develop an antibody based biosensor for the detection of glycosylated haemoglobin (HbA1c) which serves as a marker of the effectiveness of a diabetic’s blood glucose treatment regime. Monitoring HbA1c is important as many of the long term health effects of diabetes are a consequence of high blood glucose levels. The si ....New strategies for characterising and monitoring protein-surface interactions: application to a biosensor for diabetic’s blood glucose regime effectiveness. This project aims to develop an antibody based biosensor for the detection of glycosylated haemoglobin (HbA1c) which serves as a marker of the effectiveness of a diabetic’s blood glucose treatment regime. Monitoring HbA1c is important as many of the long term health effects of diabetes are a consequence of high blood glucose levels. The simple to use technology will be a general detection strategy for proteins and hence will be applicable for the detection of a wide range of diseases and biomarkers. The research will also benefit Australia by training the new generation of scientists for Australia's biomedical diagnostics industry.Read moreRead less
Lipidomics Associated with Metabolic Syndrome, Aging and Metabolic Variation between Species. The aim is to apply state-of?the-art mass spectrometry to identify and quantify alterations in membrane lipidomes (i.e. lipid classes, molecular species, structure alterations and by-products) related to two major health problems facing Australia i.e. the Metabolic Syndrome and an Ageing population plus insight into the variation in metabolic rate between organisms. This research offers the opportunity ....Lipidomics Associated with Metabolic Syndrome, Aging and Metabolic Variation between Species. The aim is to apply state-of?the-art mass spectrometry to identify and quantify alterations in membrane lipidomes (i.e. lipid classes, molecular species, structure alterations and by-products) related to two major health problems facing Australia i.e. the Metabolic Syndrome and an Ageing population plus insight into the variation in metabolic rate between organisms. This research offers the opportunity for the development of mass spectrometry based technologies for the early clinical diagnosis of metabolic disorders plus provides a template of information for our Linkage partner (AstraZeneca) to develop pharmaceutical therapies targeting key molecular lipid species identified as critical to particular membrane functions.Read moreRead less